(Q45735035)

15 December 2017

title

Malignancies after heart transplantation: presence of Epstein-Barr virus and cytomegalovirus (English)

1 reference

15 December 2017

0 references

1 reference

7

Hedman K

1 reference

15 December 2017

Mattila PS

1

1 reference

15 December 2017

Aalto SM

2

1 reference

15 December 2017

Heikkilä L

3

1 reference

15 December 2017

Mattila S

4

1 reference

15 December 2017

Nieminen M

5

1 reference

15 December 2017

Auvinen E

6

1 reference

15 December 2017

Tarkkanen J

8

1 reference

15 December 2017

publication date

1 October 2001

1 reference

15 December 2017

published in

Clinical Transplantation

1 reference

15 December 2017

volume

15

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

337-342

1 reference

Epstein-Barr virus in AIDS-related primary central nervous system lymphoma

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Treatment of organ transplant-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Alteration in the coding potential and expression of H-ras in human cytomegalovirus-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

Posttransplant malignancies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

Malignant neoplasms following cardiac transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150506.X

7 January 2021

10.1034/J.1399-0012.2001.150506.X

Identifiers

DOI

1 reference

15 December 2017

1 reference